Drug profile · INN
daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride
XIMENCY
daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride (XIMENCY) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride (XIMENCY) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride
Brand XIMENCY
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride?
daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride (XIMENCY) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride?
XIMENCY is a marketed brand name for daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.